NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed
Agency: Food and Drug Administration
- 93.876 -- Antimicrobial Resistance Surveillance in Retail Food Specimens
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
Funding Opportunity Announcement (FOA) issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), builds upon the National Antimicrobial Resistance Monitoring System (NARMS) which was initiated in 1996 as one of the key activities in a national action plan to combat antibiotic resistance threats. The purpose of this FOA is to protect and promote public health by enhancing, strengthening and sustaining antibiotic resistance surveillance in retail food specimens within the NARMS program. The NARMS cooperative agreements is intended to improve the detection of antibiotic resistance among bacteria in food commodities, as well as expand to new sites to expand the scope of sampling. Measurable outcomes of the program will be in alignment with the NARMS Objectives.
Eligibility
Eligible applicants
Miscellaneous
- Other
Additional information
Grantor contact information
Description
Work Email
Documents
No documents are currently available.
Link to additional information
Archived: June 2, 2022
Award
$5,000,000
Program Funding
50
Expected awards
$200,000
Award Minimum
$200,000
Award Maximum
Funding opportunity number:
PAR-20-124
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Agriculture
Food and nutrition
Consumer protection
Category Explanation:
History
Version:
2
Posted date:
March 6, 2020
Archive date:
June 2, 2022
